Immunomedics, inc. (IMMU)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

-93,079

-99,639

-94,323

-75,953

-87,404

-93,540

-64,209

-117,040

-35,558

-2,527

-118,762

-53,268

-59,320

-24,448

-16,228

-15,925

-14,021

-13,772

-15,416

-12,427

-11,788

-11,465

-12,442

-11,873

-9,533

-8,897

-5,226

-7,710

8,580

-5,189

-7,166

-6,977

-7,297

20,666

-5,126

3,083

-7,603

-3,427

-6,465

Adjustments to reconcile net loss to net cash used in operating activities:
Changes in fair value of warrant liabilities

-

-

-

-

-

-186

-1,218

58,835

-9,835

-26,767

86,378

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

960

969

992

1,035

804

1,509

591

357

313

414

213

266

173

233

225

233

168

168

167

169

127

140

140

145

109

157

157

270

287

238

239

393

368

367

367

382

283

405

405

Loss on disposal of property and equipment

-87

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on insurance claim for equipment failure

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

137

-

-

-

0

27

0

151

100

Amortization of discounts of auction rate securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

60

59

Interest on non-recourse debt

-13,482

9,907

9,649

30,335

-9,962

9,533

9,755

9,164

10,626

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on induced exchanges of debt

-

-

-

-

-

-

0

-

-

-

-13,005

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of deferred revenue

-

-

-

-

-

0

94

0

-13

73

17

20

18

10

15

30

3

-8

10

-3

-2

14

-3

142

39

-23

2,515

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of bond premiums

-

-

-

-

-

0

-3

-30

-6

-8

14

-12

-45

-65

-94

-131

-157

-175

-205

-236

-73

-98

-135

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs

8

12

13

12

13

143

36

126

-53

36

1,569

182

182

182

182

182

182

182

182

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash lease expense

70

68

66

66

64

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of deferred rent

-

-

-

-

-

-23

-109

-109

-109

-69

9

8

9

-2

-24

-174

24

24

24

24

24

24

24

24

24

24

24

24

24

24

24

-

24

41

75

-

26

26

26

Loss on sale of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-0

-0

0

-15

0

0

0

1

0

0

2

7

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in allowance for doubtful accounts

-

-

-

-

-

0

0

-2

-11

0

3

-9

-6

-35

-10

-11

17

-4

17

-13

0

-18

-2

27

0

-9

21

2

-10

-11

14

14

-0

11

-2

-

-

-

-

Other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

169

-31

150

Gain on sale of auction rate securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

495

0

-40

Non-cash expense related to stock-based compensation

3,848

4,409

3,180

2,404

1,743

-848

1,734

1,352

1,330

758

584

1,739

1,147

671

774

900

874

1,069

896

671

602

954

561

814

862

1,122

418

528

534

738

463

488

523

603

444

-

-

-

-

Non-cash expense relating to issuance of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

426

Non-cash decrease in value of life insurance policy

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

51

-41

4

4

-16

4

4

4

-

9

9

9

-

-4

14

14

Changes in other operating assets and liabilities

-2,751

-

-16,815

15,471

-20,141

-

-13,396

-9,572

-884

15,128

3,520

-

-

-1,061

1,870

-

1,515

-3,674

-584

-

0

183

-2,479

-

-2,169

379

139

-

-2,678

-248

820

-

850

-2,622

1,801

-

-766

-900

1,433

Net cash used in operating activities

-71,873

-92,664

-62,605

-12,496

-54,677

-81,012

-49,652

-37,471

-32,176

-43,208

-20,570

-14,064

-16,677

-14,700

-16,808

-12,543

-14,094

-8,473

-13,349

-8,616

-10,805

-10,467

-9,106

-9,248

-6,317

-7,860

-7,263

-6,471

11,914

-3,954

-7,388

-6,099

21,176

-4,114

-6,053

3,055

-6,336

-1,800

-7,104

Cash flows from investing activities
Purchases of marketable securities

-

-

-

-

-

0

0

0

135

9,999

245

-

-

-

-

-0

0

749

2,000

-

-

-

-

24,018

-30

44

20,082

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sales/maturities of marketable securities

-

-

-

-

-

0

21,818

25,269

26,881

27,837

15,124

14,942

17,490

12,038

12,712

12,829

11,892

11,836

14,292

7,742

7,270

11,281

8,196

5,008

4,015

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

473

335

815

3,635

2,064

8,029

3,184

5,045

2,940

1,200

789

1,007

98

83

647

795

200

540

689

342

141

107

331

60

103

69

144

182

219

96

97

190

76

108

193

207

37

48

312

Proceeds from sales and redemptions of auction rate securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

8,588

0

957

Net cash used in investing activities

-473

-335

-815

-3,635

-2,064

-8,029

18,634

20,224

23,806

16,636

14,090

-88,514

17,391

-17,205

12,064

12,034

11,691

10,546

11,602

3,391

-71,925

7,929

7,864

-18,670

3,942

-113

-20,227

-182

-219

-96

39

-190

-76

-108

-193

-179

8,701

-48

744

Cash flows from financing activities:
Proceeds from insurance claim for equipment failure

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

137

-

-

-

0

27

151

0

100

Exercise of stock options, net

32

272

175

281

1,825

45

131

1,263

333

53

612

2,477

1,707

0

105

2,574

0

15

142

-

-

-

-

136

587

165

910

204

-0

2

59

156

0

10

5

231

6

0

5

Exercise of warrants

-

-

-

-

-

1,313

375

22,500

5,250

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from public offering of common stock

-

-

-

-

-

0

0

-

-

-

5,906

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the issuance of non-recourse debt

-

-

-

-

-

0

0

-1

182,217

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Debt conversion fees

-

-

-

-

-

0

0

0

3

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Tax withholding payments for stock-based compensation

-

-

-

-

-

25

167

0

1,472

0

51

97

254

88

105

51

131

102

83

66

297

134

86

44

69

57

159

-

-

-

-

-

-

-

-

-

-

-

-

Payments for stock plan activity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30

35

138

-

25

22

26

-

-

-

-

Net cash provided by financing activities

32

339,071

175

6,110

1,825

1,333

339

323,229

254,109

44,514

6,048

124,161

16,153

28,489

-0

2,523

-131

-86

58

2,388

96,469

-53

-86

29,900

517

107

751

157

14,758

-72

-78

133

1,556

-12

-21

135

6

0

5

Effect of changes in exchange rates on cash, cash equivalents and restricted cash

-19

2

-10

-5

-9

-26

4

-146

47

57

-2

-87

19

-37

5

-19

27

-54

20

226

-523

-4

-187

-9

37

32

57

24

-56

2

109

-56

60

-79

-178

-

-

-

-

Net decrease in cash, cash equivalents and restricted cash

-72,333

246,074

-63,255

-10,026

-54,925

-87,734

-30,675

305,836

245,786

18,000

-434

21,495

16,887

-3,453

-4,739

1,994

-2,506

1,931

-1,667

-2,610

13,214

-2,596

-1,516

1,971

-1,820

-7,833

-26,682

-6,471

26,397

-4,120

-7,317

-6,212

22,716

-4,316

-6,446

3,395

2,372

-1,849

-6,354

Supplemental disclosure of cash flow information:
Interest paid

169

0

169

0

169

0

475

0

475

0

2,375

0

2,375

0

2,375

0

2,375

0

2,427

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Schedule for non-cash investing and financing activities:
Issuance of common shares for debt conversion

-

-

-

-

-

13,757

0

120,219

17,760

0

80,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued capital expenditures

132

101

-404

-2,736

3,140

-1,654

2,449

734

1,439

1,054

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash component of warrant exercise

-

-

-

-

-

5,793

1,776

-70,149

17,760

41,147

11,242

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Shares received in cashless exercise

0

0

-1

1

1,271

1,816

634

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock due to debt conversion

7,114

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash lease expense

70

-

-

-

64

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in operating lease liabilities

81

-

-

-

37

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Market Offering
Proceeds from private offering of common stock

-

-

-

-

-

0

0

-118,259

67,784

50,894

-419

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-